Skip To Main Content
Alexander Abitbol on Muck Rack

Alexander Abitbol

As seen in: Wiley Online Library, Diabetes Research and Clinical Practice
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Alexander Abitbol’s profile

Articles by Alexander Abitbol

Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study - Chu - Diabetic Medicine - Wiley Online Library

|
By Lisa Chu, LMC Diabetes, Alexander Abitbol
| Wiley Online Library Verified
What is already known? Continuous glucose monitoring (CGM) improves glycaemia in people living with diabetes. Recent studies showed further glycaemic improvement after switching from intermittently scanned CGM (isCGM) to real-time CGM (rtCGM). The real-world effectiveness of switching from isCGM to rtCGM in a Canadian population is underreported. What this study has found?
Open in Who Shared Issue with article?

Patient Reported Outcomes Following Initiation of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes in a Specialist Endocrinology Practice of the LMC Diabetes Registry: The PROGRESS-Diabetes Study

|
By Alexander Abitbol, Harpreet S. Bajaj, Ronald Goldenberg
| Diabetes Research and Clinical Practice Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figure 1 DiabMedSat change scores (panel A), ARMS-D change scores (panel B) and TRIM-D Device follow-up scores (panel C) in the dulaglutide (black bars) and liraglutide (grey bars) treatment cohorts. DiabMedSat: the total score and the three sub-scales range from 0-100. A higher score indicates higher satisfaction. ARMS-D: the total score ranges from 11 to 44.
Open in Who Shared Issue with article?

First Assessment of the Performance of an Implantable CGM System Through 180 Days in a Primarily Adolescent Population with Type I Diabetes

|
By Ronnie Aronson, LMC Diabetes, Alexander Abitbol, Katherine S. Tweden
| Wiley Online Library Verified
The full text of this article hosted at iucr.org is unavailable due to technical difficulties.
Open in Who Shared Issue with article?
Show More